+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Dietary supplementation with fish oil in ulcerative colitis



Dietary supplementation with fish oil in ulcerative colitis



Annals of Internal Medicine 116(8): 609-614



Objective: To determine the efficacy of fish oil supplementation in patients with active ulcerative colitis. Design: Multicenter, randomized, double-blind, placebo-controlled, crossover trail with 4-month treatment periods (fish oil and placebo) separated by a 1-month washout. Setting: Four gastroenterology divisions. Patients: Twenty-four patients with active ulcerative colitis entered the study. Five dropped out, and one was noncompliant. Eighteen patients completed the study. All patients had active disease as manifested by diarrhea and rectal inflammation. Interventions: Treatment with prednisone and sulfasalazine was continued. Fish oil supplementation consisted of 18 Max-EPA (eicosapentaenoic acid) capsules daily (eicosapentaenoic acid, 3.24 g; and docosahexaenoic acid, 2.16 g). Placebo supplementation consisted of 18 identical capsules containing isocaloric amounts of vegetable oil. Measurements: Patients were evaluated at study entry and after each diet period. Evaluations included a review of symptoms, flexible sigmoidoscopy, rectal biopsy, are rectal dialysis to measure prostaglandin E2 and leukotriene B4 levels. Results: Fish oil supplementation resulted in a significant decrease in rectal dialysate levels of leukotriene B4 from 71.0 to 27.7 pg/mL (average change, -43.3 pg/mL; 95% Cl, -83 to -3.6). Significant improvements were seen in acute histology index (average change, -8.5 units from a baseline of 10.5 units; Cl, -12.9 to -4.2) and total histology index (average change, -8.5 units from a baseline of 14.80; Cl, -13.2 to -3.8) as well as significant weight gain (average weight gain, 1.74 kg, Cl, 0.94 to 2.54). No significant changes occurred in any variable during the placebo period. Seven patients received concurrent treatment with prednisone. During the fish oil supplementation period, the mean prednisone dose decreased from 12.9 mg/d to 6.1 mg/d and rose from 10.4 mg/d to 12.9 mg/d during the placebo diet period (P > 0.20). Conclusions: Four months of diet supplementation with fish oil in patients with inflammatory bowel disease resulted in reductions in rectal dialysate leukotriene B4 levels, improvements in histologic findings, and weight gain.

(PDF emailed within 0-6 h: $19.90)

Accession: 002072132

Download citation: RISBibTeXText

PMID: 1312317

DOI: 10.7326/0003-4819-116-8-609


Related references

Fish oil supplementation and ulcerative colitis. Annals of Internal Medicine 117(6): 535; Author Reply 536, 1992

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33(7): 922-928, 1992

Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scandinavian Journal of Gastroenterology 47(1): 49-58, 2012

Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. Journal of Applied Microbiology 105(3): 706-714, 2008

Dietary unsaponifiable fraction from extra virgin olive oil supplementation attenuates acute ulcerative colitis in mice. European Journal of Pharmaceutical Sciences 48(3): 572-581, 2015

Absence of effect on faecal microflora of long-term supplementation of dietary fibres in juvenile ulcerative colitis. International Journal of Clinical Pharmacology Research 11(5): 247-252, 1991

Clinical response of ulcerative colitis with dietary supplementation by n-3 fatty acids A double-blind, randomized study. Proceedings of the Nutrition Society 59(OCB): 160A, Autumn, 2000

Clinical effect on ulcerative colitis with dietary supplementation by omega-3 fatty acids; a double blind, randomised study. Gastroenterology 118(4 Suppl 2 Part 1): AGA A588, 2000

Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. American Journal of Gastroenterology 87(4): 432-437, 1992

Dietary supplementation of catechins and alpha-tocopherol accelerates the healing of trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Journal of Nutritional Science and Vitaminology 44(6): 769-778, 1999

Dietary iron supplementation enhances dysplasia and carcinoma development in a spontaneous ulcerative colitis model in Interleukin-2 deficiency mice. Inflammatory Bowel Diseases 14: S5-S6, 2008

Dietary Supplementation With a Bacillus Superoxide Dismutase Protects Against γ-Radiation-induced Oxidative Stress and Ameliorates Dextran Sulphate Sodium-induced Ulcerative Colitis in Mice. Journal of Crohn's and Colitis 12(7): 860-869, 2018

Dietary advice both significantly reduces colitis disease activity, steroid requirement and increases quality of life in patients with ulcerative colitis. Gut 60(Suppl 1): A97-A97, 2011

Safeguard and treatment of the rectum in surgery for ulcerative colitis ulcerative recto colitis and granulomatous colitis. Clinica Terapeutica 99(2): 119-129, 1981

Folate supplementation in ulcerative colitis. Gastroenterology 98(2): 544, 1990